NHS data contract to stay with Palantir until 2029
The government says it will continue a key NHS data contract in England with the controversial US tech giant Palantir until 2029, rather than triggering an early release clause next year.
But ministers are inviting British firms to bid for the contract from 2029, with a procurement programme beginning next summer.
A Commons Committee had called on the government to part ways and appoint a company "more compatible with UK values". Protesters regularly target Palantir over Israel's use of its technology in the Gaza conflict and oppose its use in US immigration enforcement.
The £330m deal, which began in 2024 to help manage hospital waiting lists in England, was due to run until 2031.
'Albatross around the NHS's neck'
The prime minister had faced pressure from some Labour MPs to cut ties with Palantir. They said they were extremely disappointed by the decision, calling the contract "an albatross" hanging around the NHS's neck.
The Liberal Democrats said the deal was "dangerous".
There have also been concerns raised about how patient data will be used.
Palantir, which was co-founded by billionaire Peter Thiel, has interests in US defence and security, and has contracts with the Israeli military.
Health minister James Frith said the move was "not about the politics of executives of suppliers, nor is it about the territories or customers that one company or one supplier makes".
The government says UK companies will be encouraged to tender to avoid overdependence on one supplier.
The timeframe is not fast enough for some members of the government.
Dame Chi Onwurah, Labour MP for Newcastle upon Tyne Central and West, said the government needed to "act urgently" to procure "credible domestic alternatives".
"The government should not wait two years, it must start reducing this dependency now," she said.
Former Labour shadow chancellor John McDonnell went further, and accused Palantir of "human rights abuses". He said his constituents in Hayes and Harlington "expect the contract to be ended".
Liberal Democrat health spokeswoman Helen Morgan criticised the company for what she called its "appalling human rights record, run by an ally of Donald Trump".
The British Medical Association, which represents doctors, said it was glad the government had shown it was listening to its concerns about Palantir, but was frustrated the process of changing to another company was further delayed.
Palantir UK said it was right to press forward with the programme which was exceeding targets.
"We are proud of our work to date to help deliver more operations, speed up discharge and reduce the time patients need to wait to find out if they have cancer," Palantir UK senior vice-president Tom Watson said.